Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received ...

Aurora Cannabis reported quarterly revenue of CA$81.1 million, up from CA$63.1 million in the same period last year. Strong results are attributed to Aurora’s ability to capitalize on opportunities in ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Operator Greetings, and welcome to the Aurora Cannabis Inc. second quarter 2025 results conference call. [Operator instructions] This conference call is being recorded today, Wednesday, November 6, ...

Q2 2025 Earnings Call Transcript November 6, 2024 Operator: Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only ...

The first drive has taken place on the Victoria Government's closed-circuit trial to investigate whether individuals who use ...

Inc. (TSX: ACB) reported strong results in its fiscal Q2 2025 earnings, posting a 29% year-over-year increase in total revenue, reaching $81.1 million compared to $63.1 million in ...

A doctor with links to the Sunshine Coast has been reprimanded after supplying a marijuana vape to a woman which led to her ...

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

Cannabis Inc: Australia’s booming medicinal weed industrySee all 9 ... “Used under supervision, it can really do a lot of ...

Kate Kendall’s script landed at the same time as Sydney’s first Covid lockdowns. A successful fitness entrepreneur and yoga ...